DAYCLING (ISTK3)
Welcome to the PulseAid listing for the DAYCLING drug offered from ISTK3. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | ISTK3 |
NON-PROPRIETARY NAME: | magnesium stearate |
SUBSTANCE NAME: | MAGNESIUM STEARATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | VAGINAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2017-10-24 |
END MARKETING DATE: | 0000-00-00 |
DAYCLING HUMAN OTC DRUG Details:
Item Description | DAYCLING from ISTK3 |
LABELER NAME: | ISTK3 |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-10-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 71816-0001_5c42f15b-d624-bede-e053-2991aa0a0084 |
PRODUCT NDC: | 71816-0001 |
APPLICATION NUMBER: | |
Other MAGNESIUM STEARATE Pharmaceutical Manufacturers / Labelers: